High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1

BACKGROUND: Expression of programmed-death ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC) is typically evaluated through invasive biopsies; however, recent advances in the identification of circulating tumor cells (CTCs) may be a less invasive method to assay tumor cells for these purposes....

Descripción completa

Detalles Bibliográficos
Autores principales: Schehr, Jennifer L., Schultz, Zachery D., Warrick, Jay W., Guckenberger, David J., Pezzi, Hannah M., Sperger, Jamie M., Heninger, Erika, Saeed, Anwaar, Leal, Ticiana, Mattox, Kara, Traynor, Anne M., Campbell, Toby C., Berry, Scott M., Beebe, David J., Lang, Joshua M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961410/
https://www.ncbi.nlm.nih.gov/pubmed/27459545
http://dx.doi.org/10.1371/journal.pone.0159397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961410/
https://www.ncbi.nlm.nih.gov/pubmed/27459545
http://dx.doi.org/10.1371/journal.pone.0159397

Ejemplares similares